Origin of Tapentadol and its aspects    Tapentadol is authorized in the United States, Canada, and additional countries for the assistance of mild to drastic chronic discomfort. It is a centrally acting analgesic with two synergistic mechanisms of action: μ-opioid receptor agonism and inhibition of norepinephrine reuptake. The US DEA classifies tapentadol as a Schedule II...